LOL I will never have anger towards AZN & FDA, because if not for them (at least FDA), I would never have been here - I bought in right after Anchor SPA rescind.
Can someone please answer if AZN needed to get Amarin's permission to use Vascepa? If you're Amarin, is it really a wise thing to allow your competitor to run a mini trial using your drug, while you are running RI? What would have happened if Epanova showed far greater results than Vascepa - Amarin would have gotten hammered - why did Amarin management allow (if they had a right to refuse) such risk?
IMO something must have been going on the we are not aware about - and look at the coincidence, that dopey little trial happened right around SPA rescind.